Chronic myeloid leukemia stem cell biology

Area of Science:

• Hematology
• Cancer Biology
• Molecular Oncology

Background:

• Leukemia stem cells (LSC) are central to leukemia progression and relapse, exhibiting resistance to conventional therapies.
• In chronic myeloid leukemia (CML), progenitors can acquire stem cell features, leading to resistance against targeted treatments and promoting LSC behavior.

Purpose of the Study:

• To review the molecular mechanisms driving the evolution of CML LSC.
• To identify novel therapeutic targets for eradicating CML LSC while preserving normal hematopoietic stem cells.

Main Methods:

• Literature review of molecular evolution in CML LSC.
• Analysis of factors contributing to LSC survival and malignant transformation.

Main Results:

• CML LSC evolution involves cell cycle alterations, activated signaling pathways, niche interactions, and epigenetic/RNA processing deregulation.
• These factors enhance CML progenitor survival and malignant transformation.

Conclusions:

• Understanding CML LSC molecular evolution is crucial for developing effective therapies.
• Novel therapeutic targets are emerging for selective LSC eradication in chronic myeloid malignancies.